MedPath
NMPA Approval

Compound Theophylline and Ephedrine Tablets

国药准字H61023314

November 24, 2022

Drug Information

复方茶碱麻黄碱片

片剂

复方

化学药品

November 24, 2022

Company Information

Applicant Company

西安经济技术开发区沣京工业园沣京一路15号

Manufacturing Company

西安经济技术开发区沣京工业园沣京一路15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方茶碱麻黄碱片 - NMPA 批准文号 | MedPath